The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just bought a few at 67p, reduce my average a little bit ... Again.
Ripe for a takeover at this price and with the ceo departing - all lined up nicely imv.
He missed off the bit that should say "..and therefore the board and I will be foregoing our bonuses for this and next year".
Typical from docs
Looks like more of the same through 2025, I doubt the markets will like todays RNS.
Kenny Wilson, CEO, said, "The FY25 outlook is challenging, and the whole organisation is focused on our action plan to reignite boots demand, particularly in the USA, our largest market. The nature of USA wholesale is that when customers gain confidence in the market we will see a significant improvement in our business performance, but we are not assuming that this occurs in FY25.
Register your vote and join the movement. Share the link and make history together.
https://petition.parliament.uk/petitions/657294
6.6 mill there
Www.dailymail.co.uk%2Fmoney%2Fmarkets%2Findex.html
Reuters published an article at 1pm GMT today - shortly followed by / coinciding with the spike in share price:
https://www.reuters.com/markets/deals/marathon-partners-pushes-dr-martens-strategic-review-possible-sale-2024-04-02/
If in doubt trim !
Sudden jump, trying to figure out cause!!
VF Corp was the Co I previously suggested as an acquired.
Fevertreeman; I agree with your post (comparison to Birkenstock). The only little I would make, that I believe constituents a difference, is that Birkenstock haven't sacrificed the uniqueness/quality/heritage by moving to cheaper outsourced production (as far as I know). On the buyout front, agree this is ripe/inevitable at current valuation, albeit no chance of a Nike type doing it. I've posted before a couple of potential acquirers, and just today thought GIIi apparel (who produce some high end fashion names shoes) and Hannesbrands (who don't have ANY shoe brands). Neither are big enough I'd think to takeover DOCS but a merger of sorts could be advantageous - Hannesbrands 200 stores would no doubt help US distribution/sales. I don't think these US Cos even know who DOCS are (the potential, for them), but if I was the biss of Hannes, I would see a great opportunity, in DOCS, the profits of them, but also in selectively distributing their respected Haynes/Champion products in the bespoke UK centric DOCS store portfolio - call it a leverage into greater acceptance of their core in the UK/Europe.
As it is, I'm just a DOCS shareholder. But there is deep value here for the patient, and it's not if, but when, it gets taken out.
Looks like Goldmans have issued a Sell rating.
Been waiting sub 80p to add
Big drop this morning, can’t see anything around to warrant it as of yet.
Looks like the market knows something we don’t ?
See Footlocker up 9% atm.
birkenstocks is valued at us8,7bn and docs is valued at £820m. extraordinary valuation gap explained by the toxic aversion to uk market, the **** ups of management at docs over last 24 months, and the massive valuation premium for us listed stocks. birkenstock had revenues of euros 1.5bn in 2023, and dear old dr martens £1bn or euros !,17bn, so there is very little difference in revenues; birken has adjusted net profits of euro 207m ; docs had net profit of £129m (euros 150m)...................conclusion that docs is massively undervalued, and that imo it is hugely vulnerable to a swoop by birkenstocks or others...nike perhaps?
All quiet here - seems an add level
Watch the sp fly after those huge employee buys!
DOCS ,could it be the next takeover target?
Adding for me
Could Birkenstock be taking market share from Doc Martens? Could they be executing better? Was expecting a boost here not for it to go down! Egg on me face, thoughts welcome !
Assuming 130pm US GDP PC figures are good should see a boost back to £1 here, certain of it!!!